Join our
Investor Newsletter

To receive Investor News as it is released please sign up

News Releases

Renalytix to Present at Cowen 42nd Annual Health Care Conference

February 22, 2022
NEW YORK and SALT LAKE CITY, Feb. 22, 2022 (GLOBE NEWSWIRE) -- Renalytix plc (NASDAQ: RNLX) (LSE: RENX) (“Renalytix” or the “Company”) today announced the Company will be presenting at the upcoming virtual Cowen 42 nd Annual Health Care Conference. Renalytix’s management is scheduled to participate

Renalytix to Appoint Timothy Scannell to Board of Directors

February 22, 2022
NEW YORK and SALT LAKE CITY, Feb. 22, 2022 (GLOBE NEWSWIRE) -- Renalytix plc (NASDAQ: RNLX) (LSE: RENX) today announced its intention to appoint Timothy Scannell to its board of directors as an independent non-executive director. Mr. Scannell is a distinguished leader in healthcare innovation, who
Displaying 21 - 30 of 108